Congenital nephrotic syndrome with diffuse mesangial sclerosis caused by compound heterozygous mutation in LAMA5 gene.

LAMA5 gene Congenital nephrotic syndrome Diffuse mesangial sclerosis

Journal

Pediatric nephrology (Berlin, Germany)
ISSN: 1432-198X
Titre abrégé: Pediatr Nephrol
Pays: Germany
ID NLM: 8708728

Informations de publication

Date de publication:
May 2024
Historique:
received: 14 08 2023
accepted: 31 10 2023
revised: 30 10 2023
medline: 18 3 2024
pubmed: 21 11 2023
entrez: 20 11 2023
Statut: ppublish

Résumé

A two-and-a-half-month-old female infant presented with generalized edema for 10 days. At presentation, she had periorbital puffiness, moderate ascites, and pedal edema. Laboratory investigations revealed serum albumin 1.3 g/dL, spot urine protein to creatinine ratio (Up:Uc) 20.87 mg/mg, total cholesterol 380 mg/dL, and serum creatinine 0.31 mg/dL. Exome sequencing revealed compound heterozygous variants in LAMA5 gene (NM_005560.6). There was a heterozygous likely pathogenic missense variant in exon 2: LAMA5: c.385C > A (depth 195 ×) and another heterozygous pathogenic variant in exon 31: LAMA5: c.3932_3936dup; parental segregation by Sanger sequencing proved that the variants were in trans. Kidney biopsy showed diffuse mesangial sclerosis (DMS). Our case adds LAMA5 gene to the constellation of genes causing DMS, in addition to the classically described WT1, LAMB2, and PLCE1 genes and to the list of genes causing congenital nephrotic syndrome (CNS).

Identifiants

pubmed: 37985485
doi: 10.1007/s00467-023-06223-2
pii: 10.1007/s00467-023-06223-2
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1421-1425

Informations de copyright

© 2023. The Author(s), under exclusive licence to International Pediatric Nephrology Association.

Références

Joshi A, Sinha A, Sharma A, Shamim U, Uppilli B, Sharma P et al (2021) NephQuest Consortium. Next- generation sequencing for congenital nephrotic syndrome: a multi-center cross-sectional study from India. Indian Pediatr 58:445–451
doi: 10.1007/s13312-021-2215-5 pubmed: 33980730
Taniguchi Y, Nagano C, Sekiguchi K, Tashiro A, Sugawara N, Sakaguchi H et al (2021) Clear evidence of LAMA5 gene biallelic truncating variants causing infantile nephrotic syndrome. Kidney360 2:1968–1978
doi: 10.34067/KID.0004952021 pubmed: 35419533 pmcid: 8986055
Braun DA, Warejko JK, Ashraf S, Tan W, Daga A, Schneider R et al (2019) Genetic variants in the LAMA5 gene in pediatric nephrotic syndrome. Nephrol Dial Transplant 34:485–493
doi: 10.1093/ndt/gfy028 pubmed: 29534211
Jones LK, Lam R, McKee KK, Aleksandrova M, Dowling J, Alexander SI et al (2020) A mutation affecting laminin alpha 5 polymerisation gives rise to a syndromic developmental disorder. Development 147:dev189183
doi: 10.1242/dev.189183 pubmed: 32439764 pmcid: 7540250
Sunwoo Y, Choi N, Min J, Kim J, Ahn YH, Kang HG (2023) Case report: genetic defects in laminin α5 cause infantile steroid-resistant nephrotic syndrome. Front Pediatr 10:1054082
doi: 10.3389/fped.2022.1054082 pubmed: 36714636 pmcid: 9875137

Auteurs

Bobbity Deepthi (B)

Department of Pediatrics, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Pondicherry, 605006, India.

Ramge Ramachandran Sivakumar (RR)

Department of Pediatrics, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Pondicherry, 605006, India.

Sudarsan Krishnasamy (S)

Department of Pediatrics, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Pondicherry, 605006, India.

Debasis Gochhait (D)

Department of Pathology, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Pondicherry, India.

Kausik Mandal (K)

Department of Medical Genetics, Sanjay Gandhi Post-Graduate Institute of Medical Sciences, Lucknow, India.

Sriram Krishnamurthy (S)

Department of Pediatrics, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Pondicherry, 605006, India. drsriramk@yahoo.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH